The forward P/E of 8.3x stands out as a deep discount to the trailing multiple, signaling that the market expects a rapid earnings surge; if management delivers this growth, the stock could quickly re‑rate higher on a trailing basis, offering upside potential for investors.
The elevated trailing P/E places the stock at risk of a sharp correction—if earnings fall short of the implied 30% CAGR, a re‑rating to historical averages could depress the price by 15-20%, eroding near‑term upside.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 4.5% (10Y CAGR) | Analyst Rev × 36.5% margin |
| PV of FCF | $715.5M | $265.9M |
| Terminal Value (PV) | $3.49B | $6.73B |
| Enterprise Value | $4.20B | $7.00B |
| Equity Value | $4.37B | $7.16B |
| Implied Stock Price | $36.56 | $59.96 |
| Upside/Downside | +190.4% | +376.3% |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.5% | $51 | $60 | $73 | $95 | $139 |
| 5.5% | $38 | $43 | $49 | $57 | $70 |
| 6.5% | $31 | $34 | $37 | $41 | $47 |
| 7.5% | $26 | $28 | $30 | $32 | $36 |
| 8.5% | $22 | $24 | $25 | $27 | $29 |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.5% | $80 | $96 | $120 | $160 | $239 |
| 5.5% | $61 | $69 | $80 | $96 | $120 |
| 6.5% | $49 | $54 | $61 | $69 | $80 |
| 7.5% | $41 | $45 | $49 | $54 | $61 |
| 8.5% | $35 | $38 | $41 | $45 | $49 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $20.54 | +63.1% | Peer median P/E (13.5x) × Forward EPS ($1.52) |
| P/B (Peer) | $23.84 | +89.3% | Peer median P/B (1.17x) × Book Value per Share |
| EV/EBITDA (Peer) | $7.86 | -37.6% | Peer median EV/EBITDA (10.1x) × EBITDA - Net Debt |
| P/S (Peer) | $22.16 | +76.1% | Peer median P/S (2.57x) × Revenue per Share |
| DCF | $36.56 | +190.4% | Revenue × FCF Margin projection |
| Analyst Target | $14.50 | +15.2% | Consensus of 3 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net